Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

ABEOABEO
Showing 8 of 11 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in ABEONA THERAPEUTICS INC

CITADEL ADVISORS LLC holds 259,401 shares of ABEO (ABEONA THERAPEUTICS INC), worth $1.6M as of 2026-Q2. The position was increased (+364.6% shares). ABEO represents 0.0% of CITADEL ADVISORS LLC's portfolio.

Current Value

$1.6M

Current Shares

259,401

Total Value Change

+$1.6M

Total Shares Change

+258,692

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
259,401
+364.6%
$1.6M0.0%$6.18
41
2026-Q1
Decreased
55,837
-56.3%
$250,1500.0%$4.94
0
2025-Q4
Decreased
127,618
-53.3%
$672,5470.0%$5.18
0
2025-Q3
New
273,446
-
$1.4M0.0%$5.33
35
2025-Q2
Exited
0
-100.0%
$00.0%$5.75
0
2025-Q1
Increased
32,044
+2399.5%
$152,5290.0%$4.97
25
2024-Q4
Increased
1,282
+80.8%
$7,1410.0%$5.61
17
2024-Q3
Decreased
709
-83.2%
$4,4810.0%$5.89
0

Other major holders of ABEO: ADAGE CAPITAL PARTNERS GP, L.L.C., BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used